Hemostatic Agent Development

Award Information
Agency:
Department of Defense
Branch
Navy
Amount:
$70,000.00
Award Year:
2010
Program:
SBIR
Phase:
Phase I
Contract:
N00014-10-M-0481
Award Id:
98527
Agency Tracking Number:
N101-085-1139
Solicitation Year:
n/a
Solicitation Topic Code:
NAVY 10-085
Solicitation Number:
n/a
Small Business Information
55 W. L. Runnels Industrial Dr., Hattiesburg, MS, 39401
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
147162866
Principal Investigator:
JosephLichtenhan
President
(601) 544-3466
Lichtenhan@hybridplastics.com
Business Contact:
CarlHagstrom
Chief Operating Officer
(601) 544-3466
Chagstrom@hybridplastics.com
Research Institute:
n/a
Abstract
The proposed effort comprises a treatment combination using the platelet binding hemostatic capability of Nanoscopic Chemicals known as POSS trisilanols in combination with hyaluronic acid media, and antibiotic drugs in liquid and foam form. Mechanistically, liquid POSS trisilanols are injectable and serve to bind platelets to immediately stop bleeding. Subsequently the bound plateles release a multitude of natural growth factors while in the presence of a supplement of Hyaluronic acid (HA). Growth factors in combination with high amounts of HA are known to aid tissue repair and preservation.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government